McKesson Corporation (MCK) — Fair Value Analysis
Base-case fair value (P50): $763.00 · Current price: $760.57 · Verdict: Fairly Valued
The Verdict on MCK
McKesson (MCK) is currently assessed as Fairly Valued based on our latest Monte Carlo simulations. Trading at $740.57, MCK's median fair value (P50) is calculated at $724.63. This represents a marginal -2.2% difference against the current price, indicating the market is largely aligning with its fundamental valuation. Our rigorous simulations, exploring thousands of forward scenarios, position MCK squarely within a reasonable valuation range. This conclusion directly addresses whether MCK is overvalued, with the -2.2% gap supporting the Fairly Valued verdict.
How MCK stacks up against Healthcare
Within the competitive Healthcare sector, McKesson (MCK) distinguishes itself with a strong quality tier. This designation reflects robust operational and financial health when benchmarked against its industry peers, providing confidence in its underlying business performance. Companies with a strong quality tier often demonstrate superior resilience and execution, factors that contribute positively to their long-term intrinsic value stability. This fundamental strength underpins the precision of our Monte Carlo fair value assessment for MCK, currently showing a narrow -2.2% gap against its $740.57 market price, reinforcing its Fairly Valued status.
What this means for investors
For investors, MCK's Fairly Valued verdict, paired with its strong quality tier in the Healthcare sector, suggests a robust but not significantly discounted entry point at $740.57. The -2.2% difference from its median fair value of $724.63 implies that immediate alpha generation from a mispricing perspective is limited. While the Monte Carlo simulation positions MCK as Fairly Valued, understanding the full range of potential outcomes—including both significant upside and downside scenarios—is crucial for strategic positioning. Sign up for a free FairCurve account to see MCK's complete bear and bull distribution, and track its fair value daily as new fundamentals are released.
Frequently Asked Questions
Is MCK overvalued or undervalued right now?
Based on Monte Carlo simulations, McKesson (MCK) is currently assessed as Fairly Valued. Its current price of $740.57 is only -2.2% below its median fair value (P50) of $724.63.
What is the bear case and bull case for MCK?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of achieving upside, is exclusively available with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate MCK's fair value?
FairCurve calculates MCK's fair value through a sophisticated Monte Carlo simulation, running thousands of forward scenarios to determine a probabilistic range of outcomes. This robust approach generates the median fair value and the full distribution.
How can I track MCK's fair value as it changes?
To track McKesson's (MCK) fair value dynamically, add it to your free FairCurve watchlist. This provides daily fair-value updates and instant re-valuation when new earnings and other fundamental data are released.